1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
2
|
Zhang J and Wang B: Arsenic trioxide
(As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells
in vitro and in vivo. Gynecol Oncol. 103:199–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gubbels JA, Claussen N, Kapur AK, Connor
JP and Patankar MS: The detection, treatment, and biology of
epithelial ovarian cancer. J Ovarian Res. 3:82010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bailey CJ and Turner RC: Metformin. N Engl
J Med. 334:574–579. 1996. View Article : Google Scholar : PubMed/NCBI
|
5
|
Evans JM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Libby G, Donnelly LA, Donnan PT, Alessi
DR, Morris AD and Evans JM: New users of metformin are at low risk
of incident cancer: a cohort study among people with type 2
diabetes. Diabetes Care. 32:1620–1625. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zhuang Y and Miskimins WK: Cell cycle
arrest in Metformin treated breast cancer cells involves activation
of AMPK, downregulation of cyclin D1, and requires
p27Kip1 or p21Cip1. J Mol Signal. 3:182008.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Ben Sahra I, Laurent K, Loubat A, et al:
The antidiabetic drug metformin exerts an antitumoral effect in
vitro and in vivo through a decrease of cyclin D1 level. Oncogene.
27:3576–3586. 2008.PubMed/NCBI
|
9
|
Gotlieb WH, Saumet J, Beauchamp MC, et al:
In vitro metformin anti-neoplastic activity in epithelial ovarian
cancer. Gynecol Oncol. 110:246–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Cantrell LA, Zhou C, Mendivil A, Malloy
KM, Gehrig PA and Bae-Jump VL: Metformin is a potent inhibitor of
endometrial cancer cell proliferation - implications for a novel
treatment strategy. Gynecol Oncol. 116:92–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zakikhani M, Dowling R, Fantus IG,
Sonenberg N and Pollak M: Metformin is an AMP kinase-dependent
growth inhibitor for breast cancer cells. Cancer Res.
66:10269–10273. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Buzzai M, Jones RG, Amaravadi RK, et al:
Systemic treatment with the antidiabetic drug metformin selectively
impairs p53-deficient tumor cell growth. Cancer Res. 67:6745–6752.
2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Hirsch HA, Iliopoulos D, Tsichlis PN and
Struhl K: Metformin selectively targets cancer stem cells, and acts
together with chemotherapy to block tumor growth and prolong
remission. Cancer Res. 69:7507–7511. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shenhua X, Lijuan Q, Hanzhou N, et al:
Establishment of a highly metastatic human ovarian cancer cell line
(HO-8910PM) and its characterization. J Exp Clin Cancer Res.
18:233–239. 1999.PubMed/NCBI
|
15
|
Zhang S, Lin QD and Di W: Suppression of
human ovarian carcinoma metastasis by the metastasis-suppressor
gene, BRMS1. Int J Gynecol Cancer. 16:522–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Bao S, Carr ED, Xu YH and Hunt NH:
Gp91(phox) contributes to the development of experimental
inflammatory bowel disease. Immunol Cell Biol. 89:853–860. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Xu Y, Hunt NH and Bao S: The role of
granulocyte macrophage-colony-stimulating factor in acute
intestinal inflammation. Cell Res. 18:1220–1229. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Phoenix KN, Vumbaca F and Claffey KP:
Therapeutic metformin/AMPK activation promotes the angiogenic
phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
Breast Cancer Res Treat. 113:101–111. 2009. View Article : Google Scholar
|
19
|
Brem S, Cotran R and Folkman J: Tumor
angiogenesis: a quantitative method for histologic grading. J Natl
Cancer Inst. 48:347–356. 1972.PubMed/NCBI
|
20
|
Jonjic N, Peri G, Bernasconi S, et al:
Expression of adhesion molecules and chemotactic cytokines in
cultured human mesothelial cells. J Exp Med. 176:1165–1174. 1992.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|